Fornitore: LifeSign LLC
Status COVID-19/Flu A&B Test Kit (25/bx)
Descrizione
- Rapid Detection & Differentiation Between SARS-CoV-2, Flu A & B
- Accurate Results in Just 15 Minutes
- CLIA-Waived and FDA EUA Authorized
- High Sensitivity and Specificity Across All Targets
- Compatible with Nasal & Nasopharyngeal Swabs
- Complete Kit for Easy Point-of-Care Testing
- Shelf Life: 15 Months .
The LifeSign Status COVID-19/Flu A&B Test Kit is a rapid, easy-to-use immunoassay that detects and differentiates SARS-CoV-2, Influenza A, and Influenza B. This helps clinicians pinpoint the actual cause of seemingly similar symptoms, enabling fast, accurate diagnostic decisions at the point of care.
ACCURATE, FAST, AND SIMPLE TESTING
✔ COVID-19 PERFORMANCE: Anterior Nasal 93.8% / 100% | Nasopharyngeal 93.1% / 100% (Sensitivity / Specificity).
✔ FLU PERFORMANCE: Flu A: 91.4% / 95.7% | Flu B: 87.6% / 95.9% (Sensitivity / Specificity).
✔ FLEXIBLE SPECIMEN COLLECTION: Specimen is collected through anterior nasal or nasopharyngeal swabbing, within the first 5 days of symptom onset. Uses soft flocked swabs to minimize discomfort during specimen collection.
BUILT FOR POINT-OF-CARE DIAGNOSTICS
✔ CLIA-WAIVED & FDA EUA AUTHORIZED: Approved for use in patient care settings under CLIA Waiver, Certificate of Compliance, or Accreditation.
✔ COMPLETE KIT INCLUDED: Comes with flocked swabs, extraction reagents, test devices, and controls for immediate setup.
Engineered for clinical precision, the Status™ COVID-19/Flu A&B Test Kit empowers healthcare providers to diagnose respiratory infections accurately and efficiently, delivering fast answers when every minute matters.
WARNING: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.



